|
Volumn 5, Issue 8, 1996, Pages 959-976
|
Prospects for improved therapy for Helicobacter pylori infection
a a |
Author keywords
Antimicrobials; Helicobacter pylori; Therapy; Vaccines
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
ANTIULCER AGENT;
BACTERIAL VACCINE;
BISMUTH CARBONATE;
BISMUTH CITRATE;
BISMUTH GALLATE;
BISMUTH NITRATE;
BISMUTH SALICYLATE;
BISMUTH SALT;
CLARITHROMYCIN;
COLLOIDAL BISMUTH COMPOUND;
ENZYME INHIBITOR;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LACTIC ACID;
LANSOPRAZOLE;
METRONIDAZOLE;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP INHIBITOR;
RANITIDINE;
RANITIDINE BISMUTH CITRATE;
RECOMBINANT UREASE;
SOFALCONE;
SUCRALFATE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UNSATURATED FATTY ACID;
ALLERGIC REACTION;
ANIMAL MODEL;
ASTHMA;
BACTERIAL INFECTION;
CHINESE HERB;
CLINICAL TRIAL;
COLITIS;
DIARRHEA;
DRUG EFFICACY;
HELICOBACTER PYLORI;
HONEY;
HUMAN;
IMMUNIZATION;
NONHUMAN;
PATIENT COMPLIANCE;
PEPTIC ULCER;
RASH;
REVIEW;
ROTER;
STOMACH ULCER;
|
EID: 0029748611
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.8.959 Document Type: Review |
Times cited : (18)
|
References (0)
|